SIGHINOLFI, GIAN LUCA
 Distribuzione geografica
Continente #
NA - Nord America 2.267
AS - Asia 1.190
EU - Europa 890
SA - Sud America 173
AF - Africa 47
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 9
Totale 4.602
Nazione #
US - Stati Uniti d'America 2.183
SG - Singapore 429
CN - Cina 220
IT - Italia 163
GB - Regno Unito 151
FI - Finlandia 145
HK - Hong Kong 145
BR - Brasile 132
VN - Vietnam 121
SE - Svezia 115
DE - Germania 102
BD - Bangladesh 101
RU - Federazione Russa 55
CA - Canada 43
FR - Francia 42
IN - India 38
MX - Messico 27
KR - Corea 26
ID - Indonesia 20
ZA - Sudafrica 19
AR - Argentina 18
PL - Polonia 15
IQ - Iraq 13
BG - Bulgaria 12
UA - Ucraina 11
LT - Lituania 10
MY - Malesia 10
SI - Slovenia 10
AT - Austria 9
JP - Giappone 9
PK - Pakistan 9
UZ - Uzbekistan 9
AU - Australia 8
DK - Danimarca 8
ES - Italia 8
MA - Marocco 8
NL - Olanda 8
TR - Turchia 8
BE - Belgio 7
CO - Colombia 6
KE - Kenya 6
CL - Cile 5
IR - Iran 5
PH - Filippine 5
VE - Venezuela 5
JO - Giordania 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
BY - Bielorussia 3
NI - Nicaragua 3
TN - Tunisia 3
AL - Albania 2
AZ - Azerbaigian 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EC - Ecuador 2
EG - Egitto 2
IL - Israele 2
NP - Nepal 2
PT - Portogallo 2
RS - Serbia 2
AD - Andorra 1
AG - Antigua e Barbuda 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
JM - Giamaica 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MZ - Mozambico 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PY - Paraguay 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
ZM - Zambia 1
Totale 4.576
Città #
Ashburn 348
Singapore 295
Santa Clara 235
Chandler 169
Hong Kong 144
Fairfield 141
Helsinki 127
San Jose 127
Council Bluffs 81
Nyköping 76
Houston 61
London 61
Woodbridge 53
Los Angeles 51
Seattle 46
The Dalles 45
Southend 39
Beijing 37
Munich 37
New York 37
Wilmington 37
Cambridge 36
Ho Chi Minh City 32
Chicago 28
Hefei 27
Modena 26
Seoul 26
Hanoi 25
San Diego 22
Dallas 18
Princeton 18
Shanghai 18
Bremen 17
Lauterbourg 17
Turku 17
Ann Arbor 16
Jakarta 16
Johannesburg 16
Milan 16
Fremont 15
Da Nang 14
Jacksonville 14
Atlanta 13
Phoenix 13
Brooklyn 12
Sofia 12
São Paulo 12
Moscow 11
Orem 11
Portsmouth 11
Toronto 11
Warsaw 11
Chennai 9
Dearborn 9
Mexico City 9
Parma 9
Baghdad 8
Buffalo 8
Genoa 8
Montreal 8
Mumbai 8
Ottawa 8
Denver 7
Frankfurt am Main 7
Nuremberg 7
Rome 7
Salt Lake City 7
Stockholm 7
Sydney 7
Tokyo 7
Nairobi 6
Poplar 6
Redondo Beach 6
Rio de Janeiro 6
Tashkent 6
Amsterdam 5
Boston 5
Manchester 5
Amman 4
Birmingham 4
Biên Hòa 4
Boardman 4
Bologna 4
Changsha 4
Columbus 4
Dhaka 4
Dong Ket 4
Düsseldorf 4
Ghent 4
Haiphong 4
Padua 4
Philadelphia 4
Querétaro 4
San Francisco 4
San Mateo 4
Secaucus 4
Belgrade 3
Belo Horizonte 3
Bexley 3
Brussels 3
Totale 3.067
Nome #
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials 397
Carcinogenic potential of metal nanoparticles in BALB/3T3 cell transformation assay. 381
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 291
A Machine Learning Approach to Predict Weight Change in ART-Experienced People Living with HIV 289
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 286
Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 275
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 274
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 271
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 249
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients 234
Evaluation of HIV transmission clusters among natives and foreigners living in Italy 232
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: The Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) study 215
High serum levels of silica nanoparticles in systemic sclerosis patients with occupational exposure: Possible pathogenetic role in disease phenotypes 212
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 198
TB meningitis in HIV-positive patients in Europe and Argentina: Clinical dutcome and factors associated with mortality 193
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 193
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 170
Conflicting interpretations of the prevalence of mutations associated with drug resistance in antiviral naïve HIV-1 patients with acute and chronic infection 154
Tossicità in vitro di nanoparticelle metalliche in linee e colture cellulari neuronali 88
Totale 4.602
Categoria #
all - tutte 20.867
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.867


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022225 0 0 9 5 13 12 8 13 42 12 51 60
2022/2023475 69 67 36 41 58 50 14 52 41 0 19 28
2023/2024281 8 16 24 36 53 34 25 32 4 10 15 24
2024/2025917 25 10 13 79 149 139 84 41 129 43 66 139
2025/20262.017 133 74 127 232 336 166 273 83 170 194 139 90
2026/2027168 41 124 3 0 0 0 0 0 0 0 0 0
Totale 4.602